Desjardins, A., Reardon, D., Vredenburgh, J., Rich, J., Gururangan, S., Friedman, A., … Quinn, J. A. (2004). Phase I trial of adults with primary malignant glioma with irinotecan (CPT-11) plus temozolomide (Temodar). In NEURO-ONCOLOGY (Vol. 6, pp. 373–374). Toronto, CANADA: DUKE UNIV PRESS.

Desjardins, A., D. Reardon, J. Vredenburgh, J. Rich, S. Gururangan, A. Friedman, J. Sampson, et al. “Phase I trial of adults with primary malignant glioma with irinotecan (CPT-11) plus temozolomide (Temodar).” In NEURO-ONCOLOGY, 6:373–74. DUKE UNIV PRESS, 2004.

Desjardins A, Reardon D, Vredenburgh J, Rich J, Gururangan S, Friedman A, et al. Phase I trial of adults with primary malignant glioma with irinotecan (CPT-11) plus temozolomide (Temodar). In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 373–4.

Desjardins, A., et al. “Phase I trial of adults with primary malignant glioma with irinotecan (CPT-11) plus temozolomide (Temodar).” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 373–74.

Desjardins A, Reardon D, Vredenburgh J, Rich J, Gururangan S, Friedman A, Sampson J, Provenzale J, McLendon R, Herndon J, Badruddoja M, Amara J, Tourt-Uhlig S, Newton H, Friedman HS, Quinn JA. Phase I trial of adults with primary malignant glioma with irinotecan (CPT-11) plus temozolomide (Temodar). NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 373–374.